GL1X · GenesisL1 explorer

MolNFT v1 · #53914 · protein

Crystal structure of ance-trandolaprilat complex

2X93 · Angiotensin converting enzyme: “Crystal structure of ance-trandolaprilat complex”. X-ray diffraction, 5 ligands (X93, NAG, BMA), 2 pockets (best druggability 0.85). MolNFT v1 #53914 on GenesisL1: 3D structure, binding sites and…

PDB
2X93
Type
protein
Length
598 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Angiotensin converting enzyme
EC
3.4.15.1
UniProt
Q10714
Ligands
X93, NAG, BMA, MAN, ZN
Pockets
2 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 63% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAngiotensin converting enzyme (EC 3.4.15.1)protein59863% helix, 4% strandQ10714

Ligands and binding sites

  • X93 · Trandolaprilat · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • BMA · beta-D-mannopyranose · sugar · 2 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 2 copies
  • ZN · Zinc ion · metal · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15370.850.9162X93
22040.710.8839EPE

Modifications

Observed in the structure: 4 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 2X93 · Crystal structure of AnCE-trandolaprilat complex · the same entry in another collection · chain A against A, TM-score 1.00
  • Q10714 · AlphaFold monomer V2.0 prediction for angiotensin-converting enzyme (Q10714) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.